Literature DB >> 23229185

Gastrointestinal cancer: Screening cost effective, not treatment.

Lisa Hutchinson.   

Abstract

Entities:  

Year:  2012        PMID： 23229185     DOI： 10.1038/nrclinonc.2012.225

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancer.

Authors:  Ajay S Behl; Katrina A B Goddard; Thomas J Flottemesch; David Veenstra; Richard T Meenan; Jennifer S Lin; Michael V Maciosek
Journal:  J Natl Cancer Inst       Date:  2012-11-28       Impact factor: 13.506
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.